CSIMarket Company Name, Ticker, Competitors, else..
 

Abcam Plc  (NASDAQ: ABCM)

Abcam Plc's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

ABCM Sales vs. its Competitors Q4 2022


Comparing the current results to its competitors, Abcam Plc reported Revenue increase in the 4 quarter 2022 by 0 % year on year.
The revenue growth was below Abcam Plc's competitors' average revenue growth of 403.36 %, achieved in the same quarter.

• List of ABCM Competitors





Revenue Growth Comparisons




Net Income Comparison

Abcam Plc recorded a net loss, as well as most of its competitors.

<<  ABCM Stock Performance Comparisons





*Market share is calculated based on total revenue.





Publicly Traded Peers of Abcam Plc




Cryoport inc
Share Performance



-1.74%
Over The Past 5 Days
Cryoport inc
Profile

Cryoport Inc's business model revolves around providing temperature-controlled logistics solutions for the shipping of cryogenic products, including life sciences materials, cell and gene therapies, and reproductive medicine. The company utilizes its advanced technology and a global network of partners to ensure safe and secure transportation of these sensitive materials, catering to the needs of the rapidly growing biopharmaceutical industry.

More about Cryoport inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 788.884 mill. $ 182.935 mill. $ 71.738 mill.


Harvard Bioscience Inc
Share Performance



+23.38%
This Year
Harvard Bioscience Inc
Profile

Harvard Bioscience Inc's business model revolves around providing advanced tools and technologies to the life sciences research community. They offer a wide range of scientific instruments, equipment, and consumables that are used in various applications such as cell analysis, drug discovery, and next-generation sequencing.

More about Harvard Bioscience Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 36.299 mill. $ 88.164 mill. $ -10.412 mill.


Immunoprecise Antibodies Ltd
Share Performance



-12.66%
Over The Past 5 Days
Immunoprecise Antibodies Ltd
Profile

Immunoprecise Antibodies Ltd operates as a contract research organization specializing in the discovery and development of therapeutic antibodies to advance the treatment of various diseases. Through customized antibody solutions and a comprehensive portfolio of services, they offer support to pharmaceutical and biotechnology companies to accelerate their drug development processes.

More about Immunoprecise Antibodies Ltd 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 53.066 mill. $ 18.781 mill. $ -20.818 mill.

Sources: Abcam Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Abcam Plc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.